Galmed Pharmaceuticals Lt...

NASDAQ: GLMD · Real-Time Price · USD
1.79
-0.02 (-1.10%)
At close: Jun 26, 2025, 3:59 PM
1.73
-3.62%
Pre-market: Jun 27, 2025, 05:56 AM EDT
-1.10%
Bid 1.71
Market Cap 4.05M
Revenue (ttm) n/a
Net Income (ttm) -7.52M
EPS (ttm) -6.6
PE Ratio (ttm) -0.27
Forward PE -2.15
Analyst n/a
Ask 1.96
Volume 220,121
Avg. Volume (20D) 1,718,175
Open 1.78
Previous Close 1.81
Day's Range 1.75 - 1.83
52-Week Range 1.15 - 23.80
Beta 0.51

About GLMD

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
Full Company Profile
1 month ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription
9 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.